|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-1-31
|
|
pubmed:abstractText |
To assess changes in overactive bladder (OAB) symptoms and patient-reported outcomes in a post hoc analysis in which subjects from a 12-week, open-label, flexible-dose fesoterodine study were stratified according to whether they opted for dose escalation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 PFIZER INC. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
603-11
|
|
pubmed:meshHeading |
pubmed-meshheading:20860648-Adult,
pubmed-meshheading:20860648-Aged,
pubmed-meshheading:20860648-Aged, 80 and over,
pubmed-meshheading:20860648-Benzhydryl Compounds,
pubmed-meshheading:20860648-Dose-Response Relationship, Drug,
pubmed-meshheading:20860648-Epidemiologic Methods,
pubmed-meshheading:20860648-Female,
pubmed-meshheading:20860648-Humans,
pubmed-meshheading:20860648-Male,
pubmed-meshheading:20860648-Middle Aged,
pubmed-meshheading:20860648-Muscarinic Antagonists,
pubmed-meshheading:20860648-Patient Satisfaction,
pubmed-meshheading:20860648-Treatment Outcome,
pubmed-meshheading:20860648-Urinary Bladder, Overactive,
pubmed-meshheading:20860648-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible-dose study.
|
|
pubmed:affiliation |
Department of Urology, Universiteit en Universitair Ziekenhuis Antwerpen, Antwerp, Belgium. wyndaelejj@skynet.be
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
